Key result
The 2024 ESC Guidelines present controversial aspects regarding aggressive blood pressure targets and early pharmacotherapy, creating misleading discrepancies with the 2023 ESH guidelines.
The existence of two differing European guidelines for hypertension management (ESC 2024 and ESH 2023) creates confusion for physicians and patients regarding blood pressure classification, treatment initiation, and targets.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cífková et al. (2025) conducted an editorial in Elevated blood pressure and hypertension. 2024 ESC Guidelines vs. 2023 ESH Guidelines was evaluated. The 2024 ESC Guidelines present controversial aspects regarding aggressive blood pressure targets and early pharmacotherapy, creating misleading discrepancies with the 2023 ESH guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: